Intelgenx Corp.
🇨🇦Canada
Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Other: Placebo buccal film
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- IntelGenx Corp.
- Target Recruit Count
- 52
- Registration Number
- NCT03402503
- Locations
- 🇨🇦
Bruyère Research Institute, Ottawa, Ontario, Canada
🇨🇦Recherche Neuro-Hippocampe, Gatineau, Quebec, Canada
🇨🇦Gerontion Research Inc., Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath